Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
Identifieur interne : 001205 ( Main/Exploration ); précédent : 001204; suivant : 001206Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
Auteurs : Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Source :
- Rheumatology (Oxford, England) [ 1462-0332 ] ; 2018.
Descripteurs français
- KwdFr :
- Abatacept (effets indésirables), Adulte, Adulte d'âge moyen, Analyse multivariée, Anaphylaxie (), Anaphylaxie (épidémiologie), Anticorps monoclonaux humanisés (effets indésirables), Antirhumatismaux (effets indésirables), Antirhumatismaux (usage thérapeutique), Enregistrements, Facteurs de risque, Femelle, Humains, Hypertension artérielle (), Hypertension artérielle (épidémiologie), Indice de gravité médicale, Modèles logistiques, Mâle, Peptides cycliques (immunologie), Perfusions veineuses, Pharyngite (), Pharyngite (épidémiologie), Polyarthrite rhumatoïde (immunologie), Polyarthrite rhumatoïde (traitement médicamenteux), Rituximab (effets indésirables), Sujet âgé, Toxidermies (épidémiologie), Toxidermies (étiologie).
- MESH :
- effets indésirables : Abatacept, Anticorps monoclonaux humanisés, Antirhumatismaux, Rituximab.
- immunologie : Peptides cycliques, Polyarthrite rhumatoïde.
- traitement médicamenteux : Polyarthrite rhumatoïde.
- usage thérapeutique : Antirhumatismaux.
- épidémiologie : Anaphylaxie, Hypertension artérielle, Pharyngite, Toxidermies.
- étiologie : Toxidermies.
- Adulte, Adulte d'âge moyen, Analyse multivariée, Anaphylaxie, Enregistrements, Facteurs de risque, Femelle, Humains, Hypertension artérielle, Indice de gravité médicale, Modèles logistiques, Mâle, Perfusions veineuses, Pharyngite, Sujet âgé.
- Wicri :
- topic : Adulte.
English descriptors
- KwdEn :
- Abatacept (adverse effects), Adult, Aged, Anaphylaxis (chemically induced), Anaphylaxis (epidemiology), Antibodies, Monoclonal, Humanized (adverse effects), Antirheumatic Agents (adverse effects), Antirheumatic Agents (therapeutic use), Arthritis, Rheumatoid (drug therapy), Arthritis, Rheumatoid (immunology), Drug Eruptions (epidemiology), Drug Eruptions (etiology), Female, Humans, Hypertension (chemically induced), Hypertension (epidemiology), Infusions, Intravenous, Logistic Models, Male, Middle Aged, Multivariate Analysis, Peptides, Cyclic (immunology), Pharyngitis (chemically induced), Pharyngitis (epidemiology), Registries, Risk Factors, Rituximab (adverse effects), Severity of Illness Index.
- MESH :
- chemical , adverse effects : Abatacept, Antibodies, Monoclonal, Humanized, Antirheumatic Agents, Rituximab.
- chemically induced : Anaphylaxis, Hypertension, Pharyngitis.
- drug therapy : Arthritis, Rheumatoid.
- epidemiology : Anaphylaxis, Drug Eruptions, Hypertension, Pharyngitis.
- etiology : Drug Eruptions.
- immunology : Arthritis, Rheumatoid, Peptides, Cyclic.
- chemical , therapeutic use : Antirheumatic Agents.
- Adult, Aged, Female, Humans, Infusions, Intravenous, Logistic Models, Male, Middle Aged, Multivariate Analysis, Registries, Risk Factors, Severity of Illness Index.
- mix :
- Abatacept, Adult, Aged, Anaphylaxis, Antibodies, Antirheumatic Agents, Arthritis, Cyclic, Drug Eruptions, Female, Humanized, Humans, Hypertension, Infusions, Intravenous, Logistic Models, Male, Middle Aged, Monoclonal, Multivariate Analysis, Peptides, Pharyngitis, Registries, Rheumatoid, Risk Factors, Rituximab, Severity of Illness Index, biological DMARDs, infusion-related reactions, rheumatoid arthritis.
Abstract
The aim was to evaluate the incidence of serious infusion-related reactions (SIRRs) in RA treated by non-TNF-targeted biologics.
Url:
DOI: 10.1093/rheumatology/kex403
PubMed: 29069471
Affiliations:
- France
- Alsace (région administrative), Grand Est, Languedoc-Roussillon, Midi-Pyrénées, Occitanie (région administrative), Île-de-France
- Montpellier, Paris, Strasbourg, Toulouse
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000973
- to stream PubMed, to step Curation: 000973
- to stream PubMed, to step Checkpoint: 000701
- to stream Ncbi, to step Merge: 001798
- to stream Ncbi, to step Curation: 001798
- to stream Ncbi, to step Checkpoint: 001798
- to stream Hal, to step Corpus: 000054
- to stream Hal, to step Curation: 000054
- to stream Hal, to step Checkpoint: 000031
- to stream Main, to step Merge: 001204
- to stream Main, to step Curation: 001205
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.</title><author><name sortKey="Salmon, Jean Hugues" sort="Salmon, Jean Hugues" uniqKey="Salmon J" first="Jean-Hugues" last="Salmon">Jean-Hugues Salmon</name><affiliation><nlm:affiliation>Rheumatology Department, Maison Blanche Hospital, Reims University Hospitals, Reims.</nlm:affiliation><wicri:noCountry code="subField">Reims</wicri:noCountry></affiliation></author><author><name sortKey="Perotin, Jeanne Marie" sort="Perotin, Jeanne Marie" uniqKey="Perotin J" first="Jeanne-Marie" last="Perotin">Jeanne-Marie Perotin</name><affiliation><nlm:affiliation>Department of Respiratory Diseases and Allergology, Maison Blanche Hospital, Reims University Hospitals.</nlm:affiliation><wicri:noCountry code="subField">Reims University Hospitals</wicri:noCountry></affiliation></author><author><name sortKey="Morel, Jacques" sort="Morel, Jacques" uniqKey="Morel J" first="Jacques" last="Morel">Jacques Morel</name><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, University of Montpellier and Teaching Hospital Lapeyronie, Montpellier.</nlm:affiliation><country>France</country><placeName><settlement type="city">Montpellier</settlement><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Languedoc-Roussillon</region></placeName><wicri:orgArea>Department of Rheumatology, University of Montpellier and Teaching Hospital Lapeyronie</wicri:orgArea></affiliation></author><author><name sortKey="Drame, Moustapha" sort="Drame, Moustapha" uniqKey="Drame M" first="Moustapha" last="Dramé">Moustapha Dramé</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Reims Champagne-Ardenne, EA, 3797.</nlm:affiliation><wicri:noCountry code="subField">3797</wicri:noCountry></affiliation></author><author><name sortKey="Cantagrel, Alain" sort="Cantagrel, Alain" uniqKey="Cantagrel A" first="Alain" last="Cantagrel">Alain Cantagrel</name><affiliation wicri:level="3"><nlm:affiliation>Rheumatology Department, Purpan Hospital, Paul Sabatier University, Toulouse.</nlm:affiliation><country>France</country><placeName><settlement type="city">Toulouse</settlement><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region></placeName><wicri:orgArea>Rheumatology Department, Purpan Hospital, Paul Sabatier University</wicri:orgArea></affiliation></author><author><name sortKey="Ziegler, Liana Euller" sort="Ziegler, Liana Euller" uniqKey="Ziegler L" first="Liana Euller" last="Ziegler">Liana Euller Ziegler</name><affiliation><nlm:affiliation>Department of Rheumatology, L'Archet Hospital, Nice.</nlm:affiliation><wicri:noCountry code="subField">Nice</wicri:noCountry></affiliation></author><author><name sortKey="Ravaud, Philippe" sort="Ravaud, Philippe" uniqKey="Ravaud P" first="Philippe" last="Ravaud">Philippe Ravaud</name><affiliation wicri:level="3"><nlm:affiliation>Centre de Recherche en Epidémiologie et Statistiques, INSERM U1153, Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Descartes University, Paris.</nlm:affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName><wicri:orgArea>Centre de Recherche en Epidémiologie et Statistiques, INSERM U1153, Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Descartes University</wicri:orgArea></affiliation></author><author><name sortKey="Sibilia, Jean" sort="Sibilia, Jean" uniqKey="Sibilia J" first="Jean" last="Sibilia">Jean Sibilia</name><affiliation><nlm:affiliation>Department of Rheumatology, L'Archet Hospital, Nice.</nlm:affiliation><wicri:noCountry code="subField">Nice</wicri:noCountry></affiliation></author><author><name sortKey="Pane, Isabelle" sort="Pane, Isabelle" uniqKey="Pane I" first="Isabelle" last="Pane">Isabelle Pane</name><affiliation wicri:level="3"><nlm:affiliation>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg.</nlm:affiliation><country>France</country><placeName><settlement type="city">Strasbourg</settlement><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Alsace (région administrative)</region></placeName><wicri:orgArea>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg</wicri:orgArea></affiliation></author><author><name sortKey="Mariette, Xavier" sort="Mariette, Xavier" uniqKey="Mariette X" first="Xavier" last="Mariette">Xavier Mariette</name><affiliation><nlm:affiliation>Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre.</nlm:affiliation><wicri:noCountry code="subField">Le Kremlin Bicêtre</wicri:noCountry></affiliation></author><author><name sortKey="Gottenberg, Jacques Eric" sort="Gottenberg, Jacques Eric" uniqKey="Gottenberg J" first="Jacques-Eric" last="Gottenberg">Jacques-Eric Gottenberg</name><affiliation wicri:level="3"><nlm:affiliation>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg.</nlm:affiliation><country>France</country><placeName><settlement type="city">Strasbourg</settlement><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Alsace (région administrative)</region></placeName><wicri:orgArea>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg</wicri:orgArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29069471</idno><idno type="pmid">29069471</idno><idno type="doi">10.1093/rheumatology/kex403</idno><idno type="wicri:Area/PubMed/Corpus">000973</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000973</idno><idno type="wicri:Area/PubMed/Curation">000973</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000973</idno><idno type="wicri:Area/PubMed/Checkpoint">000701</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000701</idno><idno type="wicri:Area/Ncbi/Merge">001798</idno><idno type="wicri:Area/Ncbi/Curation">001798</idno><idno type="wicri:Area/Ncbi/Checkpoint">001798</idno><idno type="wicri:source">HAL</idno><idno type="RBID">Hal:hal-02338045</idno><idno type="url">https://hal.archives-ouvertes.fr/hal-02338045</idno><idno type="wicri:Area/Hal/Corpus">000054</idno><idno type="wicri:Area/Hal/Curation">000054</idno><idno type="wicri:Area/Hal/Checkpoint">000031</idno><idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000031</idno><idno type="wicri:doubleKey">1462-0324:2018:Salmon J:serious:infusion:related</idno><idno type="wicri:Area/Main/Merge">001204</idno><idno type="wicri:Area/Main/Curation">001205</idno><idno type="wicri:Area/Main/Exploration">001205</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.</title><author><name sortKey="Salmon, Jean Hugues" sort="Salmon, Jean Hugues" uniqKey="Salmon J" first="Jean-Hugues" last="Salmon">Jean-Hugues Salmon</name><affiliation><nlm:affiliation>Rheumatology Department, Maison Blanche Hospital, Reims University Hospitals, Reims.</nlm:affiliation><wicri:noCountry code="subField">Reims</wicri:noCountry></affiliation></author><author><name sortKey="Perotin, Jeanne Marie" sort="Perotin, Jeanne Marie" uniqKey="Perotin J" first="Jeanne-Marie" last="Perotin">Jeanne-Marie Perotin</name><affiliation><nlm:affiliation>Department of Respiratory Diseases and Allergology, Maison Blanche Hospital, Reims University Hospitals.</nlm:affiliation><wicri:noCountry code="subField">Reims University Hospitals</wicri:noCountry></affiliation></author><author><name sortKey="Morel, Jacques" sort="Morel, Jacques" uniqKey="Morel J" first="Jacques" last="Morel">Jacques Morel</name><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, University of Montpellier and Teaching Hospital Lapeyronie, Montpellier.</nlm:affiliation><country>France</country><placeName><settlement type="city">Montpellier</settlement><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Languedoc-Roussillon</region></placeName><wicri:orgArea>Department of Rheumatology, University of Montpellier and Teaching Hospital Lapeyronie</wicri:orgArea></affiliation></author><author><name sortKey="Drame, Moustapha" sort="Drame, Moustapha" uniqKey="Drame M" first="Moustapha" last="Dramé">Moustapha Dramé</name><affiliation><nlm:affiliation>Faculty of Medicine, University of Reims Champagne-Ardenne, EA, 3797.</nlm:affiliation><wicri:noCountry code="subField">3797</wicri:noCountry></affiliation></author><author><name sortKey="Cantagrel, Alain" sort="Cantagrel, Alain" uniqKey="Cantagrel A" first="Alain" last="Cantagrel">Alain Cantagrel</name><affiliation wicri:level="3"><nlm:affiliation>Rheumatology Department, Purpan Hospital, Paul Sabatier University, Toulouse.</nlm:affiliation><country>France</country><placeName><settlement type="city">Toulouse</settlement><region type="region" nuts="2">Occitanie (région administrative)</region><region type="old region" nuts="2">Midi-Pyrénées</region></placeName><wicri:orgArea>Rheumatology Department, Purpan Hospital, Paul Sabatier University</wicri:orgArea></affiliation></author><author><name sortKey="Ziegler, Liana Euller" sort="Ziegler, Liana Euller" uniqKey="Ziegler L" first="Liana Euller" last="Ziegler">Liana Euller Ziegler</name><affiliation><nlm:affiliation>Department of Rheumatology, L'Archet Hospital, Nice.</nlm:affiliation><wicri:noCountry code="subField">Nice</wicri:noCountry></affiliation></author><author><name sortKey="Ravaud, Philippe" sort="Ravaud, Philippe" uniqKey="Ravaud P" first="Philippe" last="Ravaud">Philippe Ravaud</name><affiliation wicri:level="3"><nlm:affiliation>Centre de Recherche en Epidémiologie et Statistiques, INSERM U1153, Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Descartes University, Paris.</nlm:affiliation><country>France</country><placeName><settlement type="city">Paris</settlement><region type="région" nuts="2">Île-de-France</region></placeName><wicri:orgArea>Centre de Recherche en Epidémiologie et Statistiques, INSERM U1153, Centre d'Épidémiologie Clinique, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris (AP-HP), Descartes University</wicri:orgArea></affiliation></author><author><name sortKey="Sibilia, Jean" sort="Sibilia, Jean" uniqKey="Sibilia J" first="Jean" last="Sibilia">Jean Sibilia</name><affiliation><nlm:affiliation>Department of Rheumatology, L'Archet Hospital, Nice.</nlm:affiliation><wicri:noCountry code="subField">Nice</wicri:noCountry></affiliation></author><author><name sortKey="Pane, Isabelle" sort="Pane, Isabelle" uniqKey="Pane I" first="Isabelle" last="Pane">Isabelle Pane</name><affiliation wicri:level="3"><nlm:affiliation>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg.</nlm:affiliation><country>France</country><placeName><settlement type="city">Strasbourg</settlement><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Alsace (région administrative)</region></placeName><wicri:orgArea>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg</wicri:orgArea></affiliation></author><author><name sortKey="Mariette, Xavier" sort="Mariette, Xavier" uniqKey="Mariette X" first="Xavier" last="Mariette">Xavier Mariette</name><affiliation><nlm:affiliation>Department of Rheumatology, Hôpitaux Universitaires Paris-Sud, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre.</nlm:affiliation><wicri:noCountry code="subField">Le Kremlin Bicêtre</wicri:noCountry></affiliation></author><author><name sortKey="Gottenberg, Jacques Eric" sort="Gottenberg, Jacques Eric" uniqKey="Gottenberg J" first="Jacques-Eric" last="Gottenberg">Jacques-Eric Gottenberg</name><affiliation wicri:level="3"><nlm:affiliation>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg.</nlm:affiliation><country>France</country><placeName><settlement type="city">Strasbourg</settlement><region type="region" nuts="2">Grand Est</region><region type="old region" nuts="2">Alsace (région administrative)</region></placeName><wicri:orgArea>Rheumatology Department, National Center for Rare Systemic Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg</wicri:orgArea></affiliation></author></analytic><series><title level="j">Rheumatology (Oxford, England)</title><idno type="eISSN">1462-0332</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abatacept (adverse effects)</term><term>Adult</term><term>Aged</term><term>Anaphylaxis (chemically induced)</term><term>Anaphylaxis (epidemiology)</term><term>Antibodies, Monoclonal, Humanized (adverse effects)</term><term>Antirheumatic Agents (adverse effects)</term><term>Antirheumatic Agents (therapeutic use)</term><term>Arthritis, Rheumatoid (drug therapy)</term><term>Arthritis, Rheumatoid (immunology)</term><term>Drug Eruptions (epidemiology)</term><term>Drug Eruptions (etiology)</term><term>Female</term><term>Humans</term><term>Hypertension (chemically induced)</term><term>Hypertension (epidemiology)</term><term>Infusions, Intravenous</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Peptides, Cyclic (immunology)</term><term>Pharyngitis (chemically induced)</term><term>Pharyngitis (epidemiology)</term><term>Registries</term><term>Risk Factors</term><term>Rituximab (adverse effects)</term><term>Severity of Illness Index</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Abatacept (effets indésirables)</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse multivariée</term><term>Anaphylaxie ()</term><term>Anaphylaxie (épidémiologie)</term><term>Anticorps monoclonaux humanisés (effets indésirables)</term><term>Antirhumatismaux (effets indésirables)</term><term>Antirhumatismaux (usage thérapeutique)</term><term>Enregistrements</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Hypertension artérielle ()</term><term>Hypertension artérielle (épidémiologie)</term><term>Indice de gravité médicale</term><term>Modèles logistiques</term><term>Mâle</term><term>Peptides cycliques (immunologie)</term><term>Perfusions veineuses</term><term>Pharyngite ()</term><term>Pharyngite (épidémiologie)</term><term>Polyarthrite rhumatoïde (immunologie)</term><term>Polyarthrite rhumatoïde (traitement médicamenteux)</term><term>Rituximab (effets indésirables)</term><term>Sujet âgé</term><term>Toxidermies (épidémiologie)</term><term>Toxidermies (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Abatacept</term><term>Antibodies, Monoclonal, Humanized</term><term>Antirheumatic Agents</term><term>Rituximab</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Anaphylaxis</term><term>Hypertension</term><term>Pharyngitis</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Arthritis, Rheumatoid</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Abatacept</term><term>Anticorps monoclonaux humanisés</term><term>Antirhumatismaux</term><term>Rituximab</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Anaphylaxis</term><term>Drug Eruptions</term><term>Hypertension</term><term>Pharyngitis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Drug Eruptions</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Peptides cycliques</term><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Arthritis, Rheumatoid</term><term>Peptides, Cyclic</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Polyarthrite rhumatoïde</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Anaphylaxie</term><term>Hypertension artérielle</term><term>Pharyngite</term><term>Toxidermies</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Toxidermies</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Infusions, Intravenous</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Registries</term><term>Risk Factors</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse multivariée</term><term>Anaphylaxie</term><term>Enregistrements</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Hypertension artérielle</term><term>Indice de gravité médicale</term><term>Modèles logistiques</term><term>Mâle</term><term>Perfusions veineuses</term><term>Pharyngite</term><term>Sujet âgé</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Adulte</term></keywords><keywords scheme="mix" xml:lang="en"><term>Abatacept</term><term>Adult</term><term>Aged</term><term>Anaphylaxis</term><term>Antibodies</term><term>Antirheumatic Agents</term><term>Arthritis</term><term>Cyclic</term><term>Drug Eruptions</term><term>Female</term><term>Humanized</term><term>Humans</term><term>Hypertension</term><term>Infusions</term><term>Intravenous</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Monoclonal</term><term>Multivariate Analysis</term><term>Peptides</term><term>Pharyngitis</term><term>Registries</term><term>Rheumatoid</term><term>Risk Factors</term><term>Rituximab</term><term>Severity of Illness Index</term><term>biological DMARDs</term><term>infusion-related reactions</term><term>rheumatoid arthritis</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim was to evaluate the incidence of serious infusion-related reactions (SIRRs) in RA treated by non-TNF-targeted biologics.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Alsace (région administrative)</li><li>Grand Est</li><li>Languedoc-Roussillon</li><li>Midi-Pyrénées</li><li>Occitanie (région administrative)</li><li>Île-de-France</li></region><settlement><li>Montpellier</li><li>Paris</li><li>Strasbourg</li><li>Toulouse</li></settlement></list><tree><noCountry><name sortKey="Drame, Moustapha" sort="Drame, Moustapha" uniqKey="Drame M" first="Moustapha" last="Dramé">Moustapha Dramé</name><name sortKey="Mariette, Xavier" sort="Mariette, Xavier" uniqKey="Mariette X" first="Xavier" last="Mariette">Xavier Mariette</name><name sortKey="Perotin, Jeanne Marie" sort="Perotin, Jeanne Marie" uniqKey="Perotin J" first="Jeanne-Marie" last="Perotin">Jeanne-Marie Perotin</name><name sortKey="Salmon, Jean Hugues" sort="Salmon, Jean Hugues" uniqKey="Salmon J" first="Jean-Hugues" last="Salmon">Jean-Hugues Salmon</name><name sortKey="Sibilia, Jean" sort="Sibilia, Jean" uniqKey="Sibilia J" first="Jean" last="Sibilia">Jean Sibilia</name><name sortKey="Ziegler, Liana Euller" sort="Ziegler, Liana Euller" uniqKey="Ziegler L" first="Liana Euller" last="Ziegler">Liana Euller Ziegler</name></noCountry><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Morel, Jacques" sort="Morel, Jacques" uniqKey="Morel J" first="Jacques" last="Morel">Jacques Morel</name></region><name sortKey="Cantagrel, Alain" sort="Cantagrel, Alain" uniqKey="Cantagrel A" first="Alain" last="Cantagrel">Alain Cantagrel</name><name sortKey="Gottenberg, Jacques Eric" sort="Gottenberg, Jacques Eric" uniqKey="Gottenberg J" first="Jacques-Eric" last="Gottenberg">Jacques-Eric Gottenberg</name><name sortKey="Pane, Isabelle" sort="Pane, Isabelle" uniqKey="Pane I" first="Isabelle" last="Pane">Isabelle Pane</name><name sortKey="Ravaud, Philippe" sort="Ravaud, Philippe" uniqKey="Ravaud P" first="Philippe" last="Ravaud">Philippe Ravaud</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001205 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001205 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:29069471
|texte= Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29069471" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |